Z79.84 is the authoritative medical code for Long term current use of oral hypoglycemic drugs. This classification is used in medical billing and clinical recording to specify the clinical criteria for long term current use of oral hypoglycemic drugs (ICD-10-CM Z79.84), ensuring healthcare documentation aligns with 2026 federal coding standards.
Billing Status: YES. This is a valid, specific, and billable ICD-10-CM reference.
Official Registry Overview & Definition
Long term current use of oral hypoglycemic drugs is a billable ICD-10-CM diagnosis code Z79.84. Includes: long term current drug use for prophylactic purposes. Inclusion terms: Long term current use of oral antidiabetic drugs. Excludes2 (not included here): long-term current use of injectable non-insulin antidiabetic drugs Z79.85; long term current use of insulin Z79.4; drug abuse and dependence F11-F19; drug use complicating pregnancy, childbirth, and the puerperium O99.32-. Code also: any therapeutic drug level monitoring Z51.81; any follow-up examination Z08-Z09.
Official Tabular Instructional Notes
Sequencing, inclusion, and exclusion notes published for Z79.84 in the official ICD-10-CM tabular list.
Includes
Conditions the official ICD-10-CM tabular list includes under this code.
- long term current drug use for prophylactic purposes
Inclusion Terms
Alternative terms the tabular list files under this code.
- Long term current use of oral antidiabetic drugs
Excludes2 — Not Included Here
Conditions not covered by this code, but which may be reported alongside it when both are present.
- long-term current use of injectable non-insulin antidiabetic drugs Z79.85
- long term current use of insulin Z79.4
- drug abuse and dependence F11-F19
- drug use complicating pregnancy, childbirth, and the puerperium O99.32-
Code Also
Additional codes that may be required to fully describe the encounter.
- any therapeutic drug level monitoring Z51.81
- any follow-up examination Z08-Z09
Frequently Asked Questions (FAQ) & Clinical Guidance
Can Z79.84 be reported alongside related conditions?
Per Excludes2 instructions, Z79.84 and the following may both be reported when both are present: long-term (current) use of injectable non-insulin antidiabetic drugs (Z79.85); long term (current) use of insulin (Z79.4); drug abuse and dependence (F11-F19); drug use complicating pregnancy, childbirth, and the puerperium (O99.32-).
What conditions are included under Z79.84?
Long term current use of oral hypoglycemic drugs includes: Long term (current) use of oral antidiabetic drugs.
Codes in This Family (40)
Official ICD-10-CM classifications in the same code family as Z79.84, with their registry titles.
- Z79 — Long term (current) drug therapy
- Z79.0 — Long term (current) use of anticoagulants and antithrombotics/antiplatelets
- Z79.01 — Long term (current) use of anticoagulants
- Z79.02 — Long term (current) use of antithrombotics/antiplatelets
- Z79.1 — Long term (current) use of non-steroidal anti-inflammatories (NSAID)
- Z79.2 — Long term (current) use of antibiotics
- Z79.3 — Long term (current) use of hormonal contraceptives
- Z79.4 — Long term (current) use of insulin
- Z79.5 — Long term (current) use of steroids
- Z79.51 — Long term (current) use of inhaled steroids
- Z79.52 — Long term (current) use of systemic steroids
- Z79.6 — Long term (current) use of immunomodulators and immunosuppressants
- Z79.60 — Long term (current) use of unspecified immunomodulators and immunosuppressants
- Z79.61 — Long term (current) use of immunomodulator
- Z79.62 — Long term (current) use of immunosuppressant
- Z79.620 — Long term (current) use of immunosuppressive biologic
- Z79.621 — Long term (current) use of calcineurin inhibitor
- Z79.622 — Long term (current) use of Janus kinase inhibitor
- Z79.623 — Long term (current) use of mammalian target of rapamycin (mTOR) inhibitor
- Z79.624 — Long term (current) use of inhibitors of nucleotide synthesis
- Z79.63 — Long term (current) use of chemotherapeutic agent
- Z79.630 — Long term (current) use of alkylating agent
- Z79.631 — Long term (current) use of antimetabolite agent
- Z79.632 — Long term (current) use of antitumor antibiotic
- Z79.633 — Long term (current) use of mitotic inhibitor
- Z79.634 — Long term (current) use of topoisomerase inhibitor
- Z79.64 — Long term (current) use of myelosuppressive agent
- Z79.69 — Long term (current) use of other immunomodulators and immunosuppressants
- Z79.8 — Other long term (current) drug therapy
- Z79.81 — Long term (current) use of agents affecting estrogen receptors and estrogen levels
- Z79.810 — Long term (current) use of selective estrogen receptor modulators (SERMs)
- Z79.811 — Long term (current) use of aromatase inhibitors
- Z79.818 — Long term (current) use of other agents affecting estrogen receptors and estrogen levels
- Z79.82 — Long term (current) use of aspirin
- Z79.83 — Long term (current) use of bisphosphonates
- Z79.85 — Long-term (current) use of injectable non-insulin antidiabetic drugs
- Z79.89 — Other long term (current) drug therapy
- Z79.890 — Hormone replacement therapy
- Z79.891 — Long term (current) use of opiate analgesic
- Z79.899 — Other long term (current) drug therapy
Indexed Clinical Terms (4)
Clinical term phrases from the official ICD-10-CM Index to Diseases and Injuries that map to this code.
- Long-term (current) (prophylactic) drug therapy (use of), oral, antidiabetic
- Long-term (current) (prophylactic) drug therapy (use of), oral, hypoglycemic
- Therapy, drug, long-term (current) (prophylactic), oral antidiabetic
- Therapy, drug, long-term (current) (prophylactic), oral hypoglycemic
Related Codes & Numerical Sequence (Crawl Map)
Search engines and indexers are advised to traverse adjacent medical codes in this sub-chapter range to find correlated diagnoses or therapeutic procedures: